These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26436361)

  • 1. Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.
    Tomich LG; Núñez M; Mendes-Correa MC
    Ann Hepatol; 2015; 14(6):888-94. PubMed ID: 26436361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.
    Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
    PLoS One; 2014; 9(4):e94271. PubMed ID: 24714066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.
    Pukenyte E; Lescure FX; Rey D; Rabaud C; Hoen B; Chavanet P; Laiskonis AP; Schmit JL; May T; Mouton Y; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):78-84. PubMed ID: 17217134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes among patients admitted to hospital with antiretroviral and/or antituberculosis drug-induced liver injury.
    Mehta R; Ive P; Evans D; Menezes CN
    S Afr Med J; 2021 Apr; 111(5):474-481. PubMed ID: 34852891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India.
    Ali N; Gupta N; Saravu K
    Drug Discov Ther; 2020; 14(3):135-138. PubMed ID: 32669522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis.
    Lima Mde F; Melo HR
    Cad Saude Publica; 2012 Apr; 28(4):698-708. PubMed ID: 22488315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
    Tweed CD; Wills GH; Crook AM; Dawson R; Diacon AH; Louw CE; McHugh TD; Mendel C; Meredith S; Mohapi L; Murphy ME; Murray S; Murthy S; Nunn AJ; Phillips PPJ; Singh K; Spigelman M; Gillespie SH
    BMC Med; 2018 Mar; 16(1):46. PubMed ID: 29592805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of protionamide and para-aminosalicylic acid induced hepatotoxicity in 129 cases].
    Ge QP; Wang QF; Duan HF; Wang J; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):737-40. PubMed ID: 24433800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.
    Sobhonslidsuk A; Poovorawan K; Soonthornworasiri N; Pan-Ngum W; Phaosawasdi K
    BMC Gastroenterol; 2016 Oct; 16(1):135. PubMed ID: 27793116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
    Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An official ATS statement: hepatotoxicity of antituberculosis therapy.
    Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
    Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
    Zhao H; Wang Y; Zhang T; Wang Q; Xie W
    Med Sci Monit; 2020 Mar; 26():e920350. PubMed ID: 32145061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
    Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.